European bivalirudin utilisation in practice 2 (EUROVISION 2)

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Study drug and medical condition

• Medicinal product name:
  ANGIOX
• Medical condition to be studied:
  Percutaneous coronary intervention

Population studied

• Short description of the study population:
  Last 10 consecutive patients who underwent a percutaneous coronary infusion (PCI) and were treated with Angiox at a randomly selected number of institutions.
• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  267

Study design details

• Main study objective:
  Drug utilisation study
• Data analysis plan:
  Descriptive statistics and/or patient data listings will be used to summarise the data.Continuous variables will be summarised by means, standard deviations, medians, inter-quartile ranges, and minimum and maximum values. Categorical variables will be summarised by frequencies and percentages.